Suppr超能文献

多拉菌素对牛疥螨病的治疗和保护效果评估。

Evaluation of the therapeutic and protective efficacy of doramectin against psoroptic scabies in cattle.

作者信息

Clymer B C, Janes T H, McKenzie M E

机构信息

CAVL, Amarillo 79114 TX, USA.

出版信息

Vet Parasitol. 1997 Sep;72(1):79-89. doi: 10.1016/s0304-4017(97)00080-0.

Abstract

Three studies were conducted to evaluate the therapeutic and protective efficacy of doramectin when given by injection at a dose of 200 micrograms/kg against induced Psoroptes otis infestations of cattle. The first study investigated therapeutic efficacy. Mite infestations were established on 15 test animals held in stanchions by transfer of material from infested donor calves. Test animals were then allotted on the basis of mite counts to a treatment group (10 animals) which received doramectin and a control group (5 animals) which received saline. Skin scrapings were collected for mite counts on the day before treatment and on days 7, 14, 21 and 28 after treatment. Efficacy assessed on the basis of the proportion of animals cured by day 28 was 100%. The second study was designed to determine the duration of protective efficacy. Forty-eight scabies-free heifers were allotted to a treated group of 32 which received doramectin, and a control group of 16 which remained untreated. These treatment groups were each divided into eight subgroups. Commencing on treatment day and continuing at weekly intervals for 7 weeks, a subgroup of animals from each treatment was placed in stanchions and challenged by transfer of material from infested donor calves. Skin scrapings for mite counts were collected 7 and 14 days later. Infestations were successfully established on all untreated control calves. Doramectin prevented the establishment of infestation for three weeks and significantly (P < 0.05) reduced infestation levels for an additional two weeks. The third study established the duration of residual protection conferred by doramectin and ivermectin under contact transmission. Ninety-six scabies-free heifers were divided into two equal treatment groups. Animals in one group received doramectin and animals in the other group received ivermectin at its recommended dose of 200 micrograms/kg by subcutaneous injection. Each treatment group was then divided into eight subgroups of six animals. Commencing on treatment day and continuing at weekly intervals for 7 weeks a subgroup of animals from each treatment was exposed to purposely infested seeder animals for one week. Three animals from each treatment subgroup were then placed in individual stanchions in which grooming was prevented and the other three were placed together in a pen where normal grooming behavior was permitted. Skin scrapings for mite counts were collected at weekly intervals for up to 4 weeks. Doramectin provided complete protection against infestation for five weeks compared to four weeks for ivermectin. These periods were not influenced by grooming behavior.

摘要

进行了三项研究,以评估皮下注射剂量为200微克/千克的多拉菌素对牛诱发的耳痒螨感染的治疗和保护效果。第一项研究调查治疗效果。通过从受感染的供体犊牛转移材料,在15头饲养在畜栏中的试验动物身上建立螨感染。然后根据螨虫计数将试验动物分配到接受多拉菌素的治疗组(10头动物)和接受生理盐水的对照组(5头动物)。在治疗前一天以及治疗后第7、14、21和28天收集皮肤刮屑进行螨虫计数。根据到第28天治愈的动物比例评估的疗效为100%。第二项研究旨在确定保护效果的持续时间。将48头无疥癣的小母牛分配到接受多拉菌素的32头治疗组和16头未治疗的对照组。这些治疗组各自再分为八个亚组。从治疗日开始并以每周一次的间隔持续7周,将每个治疗组的一个亚组的动物饲养在畜栏中,并通过从受感染的供体犊牛转移材料进行攻毒。在7天和14天后收集用于螨虫计数的皮肤刮屑。所有未治疗的对照犊牛均成功建立感染。多拉菌素在三周内预防了感染的建立,并在另外两周内显著(P<0.05)降低了感染水平。第三项研究确定了多拉菌素和伊维菌素在接触传播下赋予的残余保护持续时间。将96头无疥癣的小母牛分成两个相等的治疗组。一组动物接受多拉菌素,另一组动物接受皮下注射推荐剂量200微克/千克的伊维菌素。然后将每个治疗组再分为八个亚组,每组6头动物。从治疗日开始并以每周一次的间隔持续7周,将每个治疗组的一个亚组的动物与故意感染的接种动物接触一周。然后将每个治疗亚组的三头动物单独置于防止梳理的畜栏中,另外三头一起置于允许正常梳理行为的围栏中。每周收集用于螨虫计数的皮肤刮屑,持续4周。与伊维菌素的四周相比,多拉菌素提供了五周的完全防感染保护。这些时间段不受梳理行为的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验